Peringkat dalam Saham
#4687
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early... GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
Kapitalisasi Pasar
$3.41B
Perubahan (1 hari)
-3.80%
Perubahan (1 tahun)
133.05%
Perdagangan GRAIL Inc. (GRAL)
Harga GRAL dengan kapitalisasi pasar B
Kapitalisasi pasar dari GRAIL Inc.(GRAL)
Kapitalisasi Pasar: $3.41B
Per August 2026, GRAIL Inc. memiliki kapitalisasi pasar sebesar $3.41B. Ini menjadikan GRAIL Inc. sebagai perusahaan 4687th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar GRAIL Inc. dari 2024 hingga 2026
GRAL dibandingkan dengan 5 teratas stocks paling populer
| Harga GRAL |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.088T
|
+149,210.28%
|
|
|
|
|
$4.629T
|
+135,746.88%
|
|
|
|
|
$4.118T
|
+120,736.31%
|
|
|
|
|
$3.687T
|
+108,091.57%
|
|
|
|
|
$2.800T
|
+82,059.34%
|
